HER2DX: Advances in targeted treatment of HER2-positive breast cancer

被引：0
作者：
Andujar, Juan M. Cejalvo [1 ]
机构：
[1] Hosp Clin Univ Valencia, Dept Oncol Med, Inst Invest Sanitaria INCL, Valencia, Spain
来源：
REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA | 2024年 / 37卷 / 03期
关键词：
D O I：
10.1016/j.senol.2024.100615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
[21]   Perioperative HER2 targeted treatment in early stage HER2-positive breast cancer [J].
Hong, Joohyun ;
Park, Yeon Hee .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
[22]   Treatment of HER2-positive breast cancer [J].
Figueroa-Magalhaes, Maria Cristina ;
Jelovac, Danijela ;
Connolly, Roisin M. ;
Wolff, Antonio C. .
BREAST, 2014, 23 (02) :128-136
[23]   Treatment of HER2-positive metastatic breast cancer - advances and challenges [J].
Lin, N. .
CANCER RESEARCH, 2021, 81 (04)
[24]   Dual HER2-targeted approaches in HER2-positive breast cancer [J].
Ahn, Eugene R. ;
Vogel, Charles L. .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) :371-383
[25]   Dual HER2-targeted approaches in HER2-positive breast cancer [J].
Eugene R. Ahn ;
Charles L. Vogel .
Breast Cancer Research and Treatment, 2012, 131 :371-383
[26]   RE: HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1 [J].
Bertucci, Francois ;
de Nonneville, Alexandre ;
Finetti, Pascal ;
Mamessier, Emilie .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (06) :762-763
[27]   HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab [J].
Sanchez-Bayona, Rodrigo ;
Martinez-Saez, Olga ;
Romero-Romero, Denys ;
Segui, Elia ;
Carcelero, Esther ;
Tolosa, Pablo ;
Soberino, Jesus ;
Alva, Manuel ;
Pascual, Tomas ;
Lema, Laura ;
Garcia-Fructuoso, Isabel ;
Cobos-Fernandez, Maria Angeles ;
Rey, Maria ;
Manso, Luis ;
Aguirre, Angela ;
Madariaga, Ainhoa ;
Sirenko, Valeria ;
Gonzalez-Deza, Cristina ;
Blasco, Paula ;
Mayhua, Astrid ;
Castillo, Oleguer ;
Galvan, Patricia ;
Sanfeliu, Esther ;
Villacampa, Guillermo ;
Buckingham, Wesley ;
Marin-Aguilera, Mercedes ;
Pare, Laia ;
Villagrasa, Patricia ;
Perou, Charles M. ;
Maues, Julia ;
Braso-Maristany, Fara ;
Ciruelos, Eva ;
Prat, Aleix .
NPJ BREAST CANCER, 2025, 11 (01)
[28]   Mechanisms of Resistance to HER2-Targeted Therapies in HER2-positive Breast Cancer [J].
Veeraraghavan, Jamunarani ;
Liao, Fu-Tien ;
Qin, Lanfang ;
Gordon, Tia ;
Raghavan, Alekya ;
Sabotta, Caroline ;
Kaplan, Rachel ;
Gutierrez, Carolina ;
Osborne, C. Kent ;
Rimawi, Mothaffar F. ;
Schiff, Rachel .
CANCER RESEARCH, 2024, 84 (03)
[29]   Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey [J].
Martinez-Saez, Olga ;
Cortes, Javier ;
Ciruelos, Eva ;
Marin-Aguilera, Mercedes ;
Gonzalez, Gloria ;
Pare, Laia ;
Herrera, Adriana ;
Villagrasa-Gonzalez, Patricia ;
Prat, Aleix ;
Martin, Miguel .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (08) :2060-2069
[30]   Targeted therapy in HER2-positive breast cancer (Review) [J].
Li, Shu Guang ;
Li, Li .
BIOMEDICAL REPORTS, 2013, 1 (04) :499-505
12345